- Home
- Johnson & Johnson
Johnson & Johnson
A perfect match: “How a bone marrow transplant saved my life”
Dana Pelz was just out of college and about to start a job at Johnson & Johnson when she got stunning news: She had a life-threatening blood disorder. Today, she’s not only thriving—but helping others get a chance at life through Be The Match.
Thwarting deadly diseases before they start: the new science of cancer interception
Imagine if your doctor could detect cancer before it began growing in your body, then give you medicine to prevent it from taking hold. This researcher explains how she and other scientists are working to someday make this cutting-edge concept a reality.
Janssen Pharmaceuticals releases a 2016 U.S. Transparency Report
Jennifer Taubert, Company Group Chairman, Pharmaceuticals, The Americas, explains why Janssen is sharing information around its medication pricing and other business practices.
Johnson & Johnson celebrates National Engineers Week
As part of the annual event, the company announces the recipient of the prestigious Warren Engineering Award. Meet the winner (and his fellow finalists) in this fun behind-the-scenes video.
Meet Dr. Paul Janssen: a legend in pharmacology
When Janssen Pharmaceuticals merged with Johnson & Johnson in February 1961, a fruitful collaboration that continues to this day was born. Learn about the man who coined over 100 patents and developed more than a dozen life-changing medications.
Johnson & Johnson teams up with the Ad Council to cheer on diversity
This Valentine’s Day, the company is supporting the Love Has No Labels campaign to help spread the word about embracing equality, inclusion—and love.
The next generation of cancer care: How Johnson & Johnson is working to defeat—and even prevent—the disease
From “targeted therapies” to “precision immuno-oncology,” the scientists at Janssen Oncology are looking at cancer treatment from all innovative angles. For National Cancer Prevention Month, they let us in on some of the work they’re doing to help transform cancer care as we know it.
How Johnson & Johnson is helping patients through its compassionate use program
The company’s mission is to care for the world—one person at a time. Just ask Chief Medical Officer Joanne Waldstreicher, M.D., who’s been leading the charge to improve the process by which very sick patients may apply for access to investigational medications.
Living with cancer: meet the researcher who went from designing clinical trials to being in one
When Rick Martinez learned he had cancer, his professional life at Johnson & Johnson turned personal: He suddenly found himself the subject of a clinical trial. For National Cancer Prevention Month, he shares his story.
Stopping pandemics before they strike: What you need to know about the Coalition for Epidemic Preparedness Innovations
Johnson & Johnson’s Chief Medical Officer for Global Public Health had a front row seat at the World Economic Forum this year as part of a new coalition aimed at helping to advance vaccine development for pathogens.